- Fueled by best-in-class technology and deep expertise in genome engineering and AI, PerturbAI is uniquely positioned to redefine therapeutic discovery, making it more scalable, translatable and cost
On March 16, 2026, cooling oil prices meant markets erased some of last week's losses today, though geopolitical risks lingered.
Shares of Torex Gold Resources Inc. (TSE: TXG - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of C$63.34 and traded as hig
10x Genomics (NASDAQ: TXG - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based
Decision Diagnostics (OTCMKTS:DECN - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two busines
Biotricity (OTCMKTS:BTCY - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the s
PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate
Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics co
10x Genomics (TXG) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.4 per share a year ago.
PLEASANTON, Calif., Feb. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year e
10x Genomics (NASDAQ: TXG - Get Free Report) and Zhongchao (NASDAQ: ZCMD - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ --�
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE